tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC

Immucell (ICCC) Income Statement

68 Followers

Immucell Income Statement

Last quarter (Q3 2023), Immucell's total revenue was $5.40M, an increase of 12.52% from the same quarter last year. In Q3, Immucell's net income was $-940.00K. See Immucell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 16.29M$ 18.57M$ 19.24M$ 15.34M$ 13.72M$ 10.99M
Cost of Revenue
$ 553.96K$ 10.92M$ 10.59M$ 8.48M$ 6.98M$ 5.79M
Gross Profit
$ 3.60M$ 7.65M$ 8.66M$ 6.86M$ 6.74M$ 5.19M
Operating Expense
$ -605.82K$ 9.95M$ 8.40M$ 8.24M$ 7.69M$ 7.34M
Operating Income
$ -2.55M$ -2.30M$ 257.38K$ -1.38M$ -953.91K$ -2.15M
Net Non Operating Interest Income Expense
$ 238.73K$ -195.44K$ -295.55K$ -385.25K$ -311.04K$ -413.48K
Other Income Expense
$ -7.55M$ 187.19K$ 326.51K$ 733.35K$ -2.47K$ 700.00K
Pretax Income
$ -6.52M$ -2.49M$ -69.13K$ -1.03M$ -1.27M$ -1.86M
Tax Provision
$ 1.74K$ 7.67K$ 9.16K$ -10.14K$ 28.17K$ 461.62K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.00M$ -2.49M$ -78.29K$ -1.02M$ -1.30M$ -2.32M
Basic EPS
$ -0.85$ -0.32$ -0.01$ -0.14$ -0.19$ -0.42
Diluted EPS
$ -0.84$ -0.32$ -0.01$ -0.14$ -0.19$ -0.42
Basic Average Shares
$ 30.99M$ 7.75M$ 7.59M$ 7.21M$ 6.82M$ 5.49M
Diluted Average Shares
$ 30.99M$ 7.75M$ 7.59M$ 7.21M$ 6.82M$ 5.49M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -51.86K$ 20.87M$ 18.99M$ 16.72M$ 14.68M$ 13.13M
Net Income From Continuing And Discontinued Operation
$ -6.53M$ -2.49M$ -78.29K$ -1.02M$ -1.30M$ -2.32M
Normalized Income
$ -2.24M$ -2.09M-$ -1.91M$ -1.29M$ -2.83M
Interest Expense
---$ 412.69K$ 431.79K$ 427.78K
EBIT
$ -6.68M$ -2.14M$ 245.23K$ -619.57K$ -835.63K$ -1.43M
EBITDA
$ -5.87M$ 349.99K$ 2.71M$ 1.73M$ 1.43M$ 88.44K
Currency in USD

Immucell Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis